HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Integrin-linked kinase regulates endothelial cell nitric oxide synthase expression in hepatic sinusoidal endothelial cells.

AbstractBACKGROUND & AIMS:
Portal hypertension results from endothelial dysfunction after liver injury caused in part by abnormal production of endothelial cell derived nitric oxide synthase (eNOS). Here, we have postulated that endothelial mechanosensing pathways involving integrin-linked kinase (ILK) may play a critical role in portal hypertension, eNOS expression and function. In this study, we investigated the role of ILK and the small GTP-binding protein, Rho, in sinusoidal endothelial cell (SEC) eNOS regulation and function.
METHODS:
Primary liver SECs were isolated using standard techniques. Liver injury was induced by performing bile duct ligation (BDL). To examine the expression of Rho and ILK in vivo during wound healing, SECs were infected with constitutively active Rho (V14), a dominant negative Rho (N19) and constructs encoding ILK and a short hairpin-inhibiting ILK.
RESULTS:
Integrin-linked kinase expression was increased in SECs after liver injury; endothelin-1, vascular endothelial growth factor, and transforming growth factor beta-1 stimulated ILK expression in SECs. ILK expression in turn led to eNOS upregulation and to enhance eNOS phosphorylation and NO production. ILK knockdown or ILK (kinase) inhibition reduced eNOS mRNA expression, promoter activity, eNOS expression and ultimately NO production. In contrast, ILK overexpression had the opposite effect. Inhibition of ILK activity also disrupted the actin cytoskeleton in isolated SECs. Rho overexpression suppressed phosphorylation of the serine-threonine kinase, Akt and inhibited eNOS phosphorylation. Finally, inhibition of Rho function with the RGS domain of the p115-Rho-specific GEF (p115-RGS) significantly increased eNOS phosphorylation.
CONCLUSIONS:
Our data suggest a potential role for ILK, the cytoskeleton and ILK signalling partners including Rho in regulating intrahepatic SEC eNOS expression and function.
AuthorsMahnoush S Shafiei, Songling Lui, Don C Rockey
JournalLiver international : official journal of the International Association for the Study of the Liver (Liver Int) Vol. 35 Issue 4 Pg. 1213-21 (Apr 2015) ISSN: 1478-3231 [Electronic] United States
PMID24906011 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Copyright© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Chemical References
  • Nitric Oxide
  • Nitric Oxide Synthase Type III
  • Nos3 protein, rat
  • integrin-linked kinase
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-akt
  • rho GTP-Binding Proteins
Topics
  • Animals
  • Cells, Cultured
  • Chemical and Drug Induced Liver Injury (enzymology, genetics)
  • Cholestasis (enzymology, genetics)
  • Cytoskeleton (enzymology)
  • Disease Models, Animal
  • Endothelial Cells (enzymology)
  • Enzyme Activation
  • Gene Expression Regulation, Enzymologic
  • Liver (enzymology)
  • Male
  • Nitric Oxide (metabolism)
  • Nitric Oxide Synthase Type III (genetics, metabolism)
  • Phosphorylation
  • Protein Serine-Threonine Kinases (genetics, metabolism)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • RNA Interference
  • Rats, Sprague-Dawley
  • Signal Transduction
  • Transfection
  • Wound Healing
  • rho GTP-Binding Proteins (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: